Home › Research › Disease mechanisms
The role of neutrophils, red blood cells, and platelets in the pathology of Alzheimer’s disease
Yan Xu, Xiangdong Li, Qingchun Zhao, Xiangbo Xu. Annals of Medicine, 2025-10-24
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Emerging evidence transcends the traditional central nervous system (CNS)-centric perspective, revealing that neutrophils, red blood cells (RBCs), and platelets may play critical roles in AD pathogenesis by modulating systemic inflammatory responses, disrupting blood-brain barrier integrity, and participating in the CNS-peripheral interactions. This review synthesizes recent advances in understanding the contributions of neutrophils, RBCs and platelets to AD pathology, which is promising to provide a transformative perspective and evidence for the in-depth understanding of the pathogenesis of AD and developing precision interventions against AD.
What this study adds
Evidence grade: Low
This review discusses evidence that neutrophils, red blood cells and platelets may contribute to Alzheimer's disease by affecting inflammation and the blood-brain barrier. It is a summary of ideas about disease mechanisms and does not report a treatment or cure.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Xu, Y., Li, X., Zhao, Q., & Xu, X. (2025). The role of neutrophils, red blood cells, and platelets in the pathology of Alzheimer’s disease. Annals of Medicine. https://doi.org/10.1080/07853890.2025.2575110
Vancouver
Xu Y, Li X, Zhao Q, Xu X. The role of neutrophils, red blood cells, and platelets in the pathology of Alzheimer’s disease. Annals of Medicine. 2025. doi:10.1080/07853890.2025.2575110. PMID: 41134126.
BibTeX
@article{xu2025-41134126,
author = {Xu, Yan and Li, Xiangdong and Zhao, Qingchun and Xu, Xiangbo},
title = {{The role of neutrophils, red blood cells, and platelets in the pathology of Alzheimer’s disease}},
journal = {Annals of Medicine},
year = {2025},
doi = {10.1080/07853890.2025.2575110},
pmid = {41134126},
url = {https://doi.org/10.1080/07853890.2025.2575110}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Emerging evidence transcends the traditional central nervous system (CNS)-centric perspective, revealing that neutrophils, red blood cells (RBCs), and platelets may play critical roles in AD pathogenesis by modulating systemic inflammatory responses, disrupting blood-brain barrier integrity, and participating in the CNS-peripheral interactions.
- This review synthesizes recent advances in understanding the contributions of neutrophils, RBCs and platelets to AD pathology, which is promising to provide a transformative perspective and evidence for the in-depth understanding of the pathogenesis of AD and developing precision interventions against AD.
Why it matters
This review discusses evidence that neutrophils, red blood cells and platelets may contribute to Alzheimer's disease by affecting inflammation and the blood-brain barrier. It is a summary of ideas about disease mechanisms and does not report a treatment or cure.
Study details
- Evidence strengthLow
How this study scored 35/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Annals of Medicine) |
| Journal's citation record | 2 / 4 | Annals of Medicine: journal h-index 163 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 3 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 1.0 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 2 / 6 | Cited 1.6× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 1 / 4 | Cited 3 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 1 / 4 | Last-listed author Xiangbo Xu: h-index 15 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | Shenyang Pharmaceutical University: institution h-index 287 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 2 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 41134126) |
| Free to read | 2 / 2 | Free to read |
| Total | 35 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1080/07853890.2025.2575110
- PubMed: 41134126
- Original source →
- Free full text: Annals of Medicine →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Disease mechanisms from nearby years
Also tagged “precursor”
1,337 studies in the library carry the topic tag “precursor”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,337 tagged studies.